Phosphodiesterase 5 inhibitors and nitrergic transmission—from zaprinast to sildenafil
- 1 January 2001
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 411 (1-2) , 1-10
- https://doi.org/10.1016/s0014-2999(00)00824-4
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Sildenafil in the Treatment of Sexual Dysfunction Induced by Selective Serotonin Reuptake InhibitorsCNS Drugs, 2000
- Cyclic GMP-associated apamin-sensitive nitrergic slow inhibitory junction potential in the hamster ileumBritish Journal of Pharmacology, 1999
- Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:: Research and Clinical Implications in Erectile DysfunctionTrends in Endocrinology & Metabolism, 1999
- EFFECT OF THE SELECTIVE PHOSPHODIESTERASE TYPE 5 INHIBITOR SILDENAFIL ON ERECTILE FUNCTION IN THE ANESTHETIZED DOGJournal of Urology, 1998
- THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE (PDE) INHIBITORS ON HUMAN AND RABBIT CAVERNOUS TISSUE IN VITRO AND IN VIVOJournal of Urology, 1998
- Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunctionBioorganic & Medicinal Chemistry Letters, 1996
- Non-adrenergic, non-cholinergic relaxation and levels of cyclic nucleotides in rabbit lower urinary tractEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- NG-nitro-L-arginine inhibits non-adrenergic, non-cholinergic relaxation in rabbit urethral smooth muscleLife Sciences, 1991
- cGMP: The wayward child of the cyclic nucleotide familyTrends in Neurosciences, 1991
- Cyclic Nucleotide Content of the Rat Anococcygeus During Relaxations Induced by Drugs or by Non-adrenergic, Non-cholinergic Field StimulationJournal of Pharmacy and Pharmacology, 1991